which shall be for informational purposes and 
shall not be deemed to constitute a list of the 
only acceptable non-animal test methods) of— 
(i) scientifically reliable and relevant 
non-animal test methodology as alter-
natives to animal testing that have been 
recognized by any Federal agency or an 
international regulatory agency; 
(ii) next generation risk assessment 
methods; and 
(iii) examples of alternative methods 
and strategies that have been accepted by 
the Secretary; and 
(D) to the maximum extent practicable 
given available resources, prioritize and carry 
out performance assessment, validation, and 
translational studies to accelerate the develop-
ment of scientifically valid test methods and 
strategies that replace the use of vertebrate ani-
mals. 
(2) PUBLIC MEETINGS.— 
(A) INITIAL MEETING.—Not later than 90 
days after the date of enactment of this Act, 
the Secretary shall convene a public meeting re-
VerDate Sep 11 2014 
17:08 Dec 17, 2021
Jkt 029200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H6207.IH
H6207
pamtmann on DSKBC07HB2PROD with BILLS
garding the strategic plan described in para-
graph (1)(A). 
(B) SUBSEQUENT
ANNUAL
MEETINGS.— 
Not later than 1 year after the date of the pub-
lic meeting under subparagraph (A), and annu-
ally thereafter, the Secretary shall convene a 
separate public meeting or add as an agenda 
item to an already existing meeting, in-person 
or virtually, to inform the Secretary’s advance-
ment of alternative test methods and strategies 
to replace vertebrate animal testing for assess-
ing the safety of cosmetics. The Secretary shall 
include in such meetings scientific and aca-
demic experts, animal and consumer advocacy 
groups, and the regulated industry. 
(3) RULE OF CONSTRUCTION.—Nothing in this 
subsection shall be construed to limit the authority 
of the Secretary to address other tools to promote 
the development and implementation of alternative 
test methods and strategies to replace vertebrate 
animal testing for assessing the safety of cosmetics 
as part of the strategic plan described in paragraph 
(1)(A). 
(j) CONSUMER INFORMATION RELATED TO ANIMAL 
TESTING.— 
VerDate Sep 11 2014 
17:08 Dec 17, 2021
Jkt 029200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H6207.IH
H6207
pamtmann on DSKBC07HB2PROD with BILLS
(1) IN GENERAL.—A cosmetic product manu-
facturer shall not include on the label of a cosmetic 
product or any of the product’s containers or wrap-
pers a claim that such cosmetic product was not 
tested on animals, including any claim or logo of 
‘‘cruelty free’’ if— 
(A) such cosmetic product or any ingre-
dient or nonfunctional constituent contained in 
such cosmetic product was tested on an animal 
after the effective date specified in subsection 
(a); and 
(B)(i) the testing was conducted by or con-
tracted for by the cosmetic product manufac-
turer or another person in the supply chain at 
the direction or request of the cosmetic product 
manufacturer; or 
(ii) the cosmetic product manufacturer re-
lied upon evidence from such testing, pursuant 
to subsection (c)(1)(B)(ii), to establish the safe-
ty of such product, ingredient, or nonfunctional 
constituent under chapter VI of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 361 
et seq.). 
(2) EXCEPTIONS.—Notwithstanding paragraph 
(1), a cosmetic product manufacturer may include a 
VerDate Sep 11 2014 
17:08 Dec 17, 2021
Jkt 029200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H6207.IH
H6207
pamtmann on DSKBC07HB2PROD with BILLS
claim described in such paragraph on the label of a 
cosmetic product described in such paragraph or any 
of the product’s containers or wrappers if— 
(A) such testing qualifies for the exemp-
tion under subsection (d)(4); and 
(B)(i) in the case of animal testing con-
ducted by or contracted for by the cosmetic 
product manufacturer or another person in the 
supply chain at the direction or request of the 
cosmetic product manufacturer, the cosmetic 
manufacturer did not rely upon evidence from 
such testing for the purpose of establishing the 
safety of the product, ingredient, or nonfunc-
tional constituent under chapter VI of the Fed-
eral Food, Drug, and Cosmetic Act (21 U.S.C. 
361 et seq.); or 
(ii) in the case of animal testing conducted 
by or contracted for by a person that is not de-
scribed in clause (i), evidence from which the 
cosmetic product manufacturer relied upon, 
pursuant to subsection (c)(1)(B)(ii), to estab-
lish the safety of such product, ingredient, or 
nonfunctional constituent under chapter VI of 
the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 361 et seq.), the cosmetic product man-
VerDate Sep 11 2014 
17:08 Dec 17, 2021
Jkt 029200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H6207.IH
H6207
pamtmann on DSKBC07HB2PROD with BILLS
ufacturer includes on the label a disclosure de-
scribing the circumstances surrounding the use 
of the exemption under subsection (c)(1)(B)(ii) 
by such manufacturer that includes a reference 
to the specific Federal, State, or foreign re-
quirement under which the animal testing was 
conducted or a reference to a publicly available 
internet website of such manufacturer that pro-
vides such disclosure. 
(k) REPORT.—Beginning 2 years after the date of en-
actment of this Act, the Secretary shall biennially submit 
to the Committee on Health, Education, Labor, and Pen-
sions of the Senate and the Committee on Energy and 
Commerce of the House of Representatives, and make 
available on the website of the Food and Drug Administra-
tion, a report that includes, with respect to the previous 
2 fiscal years— 
(1) updates on the Secretary’s implementation 
of this section, including developments implementing 
the strategic plan under subsection (i)(1)(A); 
(2) the number of times the Secretary re-
quested animal test data under subsection (d)(2), 
the ingredients involved, and the animal tests per-
formed; and 
VerDate Sep 11 2014 
17:08 Dec 17, 2021
Jkt 029200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H6207.IH
H6207
pamtmann on DSKBC07HB2PROD with BILLS
(3) based on the data reviewed by the Secretary 
under subsection (g)(1), the number of times manu-
facturers relied upon data pursuant to the exemp-
tion under subsection (d)(4) to establish the safety 
of a cosmetic under chapter VI of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 361 et seq.). 
(l) DEFINITIONS.— 
(1) COSMETIC.—The term ‘‘cosmetic’’ has the 
meaning given such term in section 201(i) of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
321(i)). 
(2) COSMETIC
ANIMAL
TESTING.—The term 
‘‘cosmetic animal testing’’ means the internal or ex-
ternal application or exposure of any cosmetic prod-
uct, or any cosmetic ingredient or nonfunctional con-
stituent, to the skin, eyes, or other body part (organ 
or extremity) of a live non-human vertebrate for the 
purpose of evaluating the safety or efficacy of a cos-
metic product or a cosmetic ingredient or nonfunc-
tional constituent for use in a cosmetic product. 
(3) LABEL.—The term ‘‘label’’ has the meaning 
given such term in section 201(k) of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 321(k)). 
(4) NONFUNCTIONAL CONSTITUENT.—The term 
‘‘nonfunctional constituent’’ means any incidental in-
VerDate Sep 11 2014 
17:08 Dec 17, 2021
Jkt 029200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H6207.IH
H6207
pamtmann on DSKBC07HB2PROD with BILLS
gredient as defined in section 701.3(l) of title 21, 
Code of Federal Regulations, on the date of enact-
ment of this section. 
(5) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of Health and Human Services. 
Æ 
VerDate Sep 11 2014 
17:08 Dec 17, 2021
Jkt 029200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6301
E:\BILLS\H6207.IH
H6207
pamtmann on DSKBC07HB2PROD with BILLS